I help life sciences clients protect innovations and develop effective patent strategies.
Dr. Maya Elbert is a patent attorney with more than 15 years of experience in creation, strategic management, and evaluation of intellectual property assets for life sciences clients. She develops and implements global patent strategies, manages patent portfolios, prepares patent invalidity and non-infringement opinions, and leads patent landscape analyses, freedom-to-operate analyses, and patent portfolio due diligences for financings, investments, licenses and acquisitions.
Maya has experience with third party submissions, third party observations, inter partes review, EPO opposition proceedings, patent interferences and ex parte reexaminations. She also supports licensing and collaboration agreements.
Maya’s clients include startups, mid- and large size biotech and pharma companies, universities, and investment funds. She has experience obtaining and evaluating IP covering, inter alia, antibodies, gene therapies, gene editing technology (CRISPR), RNA interference, peptide therapeutics and vaccines, cellular therapeutics (including CAR Ts and iPSCs), biomanufacturing, biosynthetic cannabinoids, biopolymers, small molecule therapies, nutritional supplements and pharmaceutical formulations.
